Drugs for Skin Atrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 20)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Cathine |
Approved, Experimental, Illicit, Vet_approved, Withdrawn |
Phase 1 |
|
14838-15-4, 492-39-7 |
131954576 4786 26934 |
Synonyms:
(+-)-Norephedrine
(+)-Norpseudoephedrine
(+-)-Phenylpropanolamine
2-AMINO-1-PHENYLPROPAN-1-OL
Cathina
Cathine
Cathinum
D-Cathine
Dexatrim
DL-Norephedrine
DL-Phenylpropanolamine
D-Norephedrine
d-Norpseudoephedrine
d-Nor-psi-ephedrine
FENILPROPANOLAMINA
Hydriatine
Hydrochloride, phenylpropanolamine
Katine
L-NOREPHEDRINE
L-Phenyl propanolamine
|
Mucorama
Nobese
NOREPHEDRIN
Norephedrine
Obestat
PHENYLPROPANOLAMIN
Phenylpropanolamina
Phenylpropanolamine
PHÉNYLPROPANOLAMINE
Phenylpropanolamine hydrochloride
PHENYLPROPANOLAMINUM
PPA
Prestwick_388
Prolamine
Propadrine
Propagest
Pseudonorephedrine
psi-Norephedrine
Triaminic DM
Î’-HYDROXYAMPHETAMINE
|
|
2 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 1 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
AMONIDRON
Aresol
Benylin-e
Breonesin
Bronchol
CVT-2534
Ether, guaiacol glyceryl
FAMEL
FRANOLYN CHESTY
GECOLATE
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
|
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
GUAIFENESIN OR GUAIPHENESIN
Guaifenesina
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
HUMABID
Humibid
Hustosil
Hytuss
LIQUFRUTA
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
MUCINEX
NIROLEX FOR CHESTY COUGH DECONGESTANT
NSC-62112
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
TIXYLIX CHESTY COUGH
|
|
3 |
|
Clobetasol |
Approved, Experimental, Investigational |
Phase 1 |
|
25122-46-7, 25122-41-2 |
2791 5311051 32798 |
Synonyms:
(11b,16b)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11beta,16beta)-21-Chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11Β,16β)-21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
14-(2-Chloroacetyl)-1-fluoro-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl propanoic acid
21-CHLORO-9-FLUORO-11BETA,17-DIHYDROXY-16BETA-METHYLPREGNA-1,4-DIENE-3,20-DIONE 17-PROPIONATE
21-CHLORO-9-FLUORO-11Î’,17-DIHYDROXY-16Î’-METHYLPREGNA-1,4-DIENE-3,20-DIONE 17-PROPIONATE
CCI-4725
CCI-4725|Clobex®|Dermovate®|GR 2/925|Temovate®
CLARELUX
CLOBADERM
Clobecort amex
CLOBETASOL
Clobetasol 17 propionate
CLOBETASOL 17-PROPANOATE
Clobetasol 17-propionate
Clobetasol propionate
CLOBETASOL PROPIONATE (EMOLLIENT)
|
CLOBETASOL PROPIONATE E
Clobetasol propionic acid
Clobetasolum
Clobex
Clofenazon
Cormax
Dermovate
DERMOVATE NN
Embeline
Embeline e
ETRIVEX
GR 2/925
IMPOYZ
OLUX
OLUX E
Temovate
TEMOVATE E
|
|
4 |
|
Betamethasone |
Approved, Vet_approved |
Phase 1 |
|
378-44-9 |
9782 |
Synonyms:
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16b-Methyl-1,4-pregnadiene-9a-fluoro-11b,17a,21-triol-3,20-dione
16Β-methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
9a-Fluoro-16b-methylprednisolone
9alpha-Fluoro-16beta-methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-Fluoro-16b-methylprednisolone
9-Fluoro-16β-methylprednisolone
9Α-fluoro-16β-methylprednisolone
ALPHATREX
BESAMESTAZONA
Betadexamethasone
Betametasona
BETAMETHASONE
Bétaméthasone
beta-Methasone alcohol
Betamethasonum
BETAMETHASONVALERAT MIKRON
BETASOLAN
|
BETATREX
BETA-VAL
BETNELAN
b-Methasone alcohol
Celeston
Celestona
Celestone
Cellestoderm
DERMABET
Flubenisolone
LOTRISONE
NSC-39470
Rinderon
SCH-4831
TACLONEX
UTICORT
VISUBETA
Î’-methasone alcohol
|
|
5 |
|
Petrolatum |
Approved, Investigational |
Phase 1 |
|
8009-03-8 |
|
Synonyms:
Multi-hydrocarbon
Paraffinum album
Paraffinum flavum
Petrolatum
Petrolatum base
Petrolatum, white
Petrolatum,amber
|
Petrolatum,white
Petroleum jelly
Soft paraffin
White petrolatum
White, soft paraffin
Yellow soft paraffin
|
|
6 |
|
Prasterone |
Approved, Investigational, Nutraceutical |
Phase 1 |
|
53-43-0 |
5881 |
Synonyms:
(+)-Dehydroisoandrosterone
(3beta)-3-Hydroxy-androst-5-en-17-one
(3-beta)-3-Hydroxyandrost-5-en-17-one
(3beta,16alpha)-3,16-Dihydroxy-androst-5-en-17-one
17-Chetovis
17-Hormoforin
3beta-Hydroxy-5-androsten-17-one
3-BETA-HYDROXY-5-androsten-17-one
3beta-Hydroxyandrost-5-en-17-one
3beta-Hydroxy-androst-5-en-17-one
3-beta-Hydroxyandrost-5-en-17-one
3beta-Hydroxy-D5-androsten-17-one
3-b-HYDROXY-5-androsten-17-one
3b-Hydroxyandrost-5-en-17-one
3b-Hydroxy-D5-androsten-17-one
3-Î’-hydroxy-5-androsten-17-one
3Î’-hydroxyandrost-5-en-17-one
5 Androsten 3 beta hydroxy 17 one
5 Androsten 3 ol 17 one
5,6-Dehydroisoandrosterone
5,6-Didehydroisoandrosterone
5-Androsten-3-beta-hydroxy-17-one
5-Androsten-3beta-ol-17-one
5-Androsten-3-beta-ol-17-one
5-Androsten-3b-ol-17-one
5-Androsten-3-ol-17-one
5-Dehydroepiandrosterone
5-Dehydro-epiandrosterone
Andrestenol
Androst-5-ene-3beta-ol-17-one
Androst-5-ene-3b-ol-17-one
|
Androsten-3beta-ol-17-one
Androstenolone
Astenile
Biolaif
D5-Androsten-3beta-ol-17-one
D5-Androsten-3b-ol-17-one
Deandros
DEHYDROANDROSTERONE
Dehydro-epi-androsterone
DEHYDROEPIANDROSTERONE
Dehydroisoandrosterone
DHA
DHEA
Diandron
Diandrone
EM-760
EM-760Dehydroandrosterone
ENZYMATIC THERAPY
Hydroxyandrostenone
Intrarosa
NATROL DHEA
NSC-9896
Prasterona
Prasterone
Prasterone, 3 alpha isomer
Prasterone, 3 alpha-isomer
Prasteronum
Prestara
Psicosterone
trans-Dehydroandrosterone
|
|
7 |
|
Chlorpheniramine, phenylpropanolamine drug combination |
|
Phase 1 |
|
|
|
8 |
|
DHEA (Dehydroepiandrosterone) |
|
Phase 1 |
|
|
|
9 |
|
glucocorticoids |
|
Phase 1 |
|
|
|
10 |
|
Hormones |
|
Phase 1 |
|
|
|
11 |
|
Hormone Antagonists |
|
Phase 1 |
|
|
|
12 |
|
Anti-Inflammatory Agents |
|
Phase 1 |
|
|
|
13 |
|
Anti-Asthmatic Agents |
|
Phase 1 |
|
|
|
14 |
|
Betamethasone-17,21-dipropionate |
|
Phase 1 |
|
|
|
15 |
|
Betamethasone Valerate |
|
Phase 1 |
|
2152-44-5 |
|
Synonyms:
AUDAVATE
AUDAVATE RD
BETACAP
BETADERM
BETAMETH VAL 0.1% 50% IN EMULSIF
BETAMETH VAL IN COAL TAR
BETAMETH VAL OINT 0.1% 25%COAL TAR
BETAMETH VAL OINT 0.1% 50% COALTAR
BETAMETH VAL OINT0.025% 50%COALTAR
BETAMETHASONE 17-VALERATE
BETAMETHASONE VALERATE
BETATREX
BETA-VAL
|
BETESIL
BETNOVATE RD
BETNOVATE-C
BETNOVATE-N
BETTAMOUSSE
BEXTASOL
DERMABET
FUCIBET
LUXIQ
VALISONE
VALNAC
XEMACORT
|
|
16 |
|
Betamethasone sodium phosphate |
|
Phase 1 |
|
|
|
Synonyms:
BETAMETHASONE 21-PHOSPHATE DISODIUM SALT
BETAMETHASONE SODIUM PHOSPHATE
BETAM-OPHTAL
BETNESOL
BETNESOL-N
|
CELESTONE
NSC-90616
VISTAMETHASONE
VISTAMETHASONE N
|
|
17 |
|
Betamethasone benzoate |
|
Phase 1 |
|
|
|
Synonyms:
BETAMETHASONE BENZOATE
UTICORT
|
|
|
18 |
|
Respiratory System Agents |
|
Phase 1 |
|
|
|
19 |
|
Emollients |
|
Phase 1 |
|
|
|
20 |
|
Dermatologic Agents |
|
Phase 1 |
|
|
|
Interventional clinical trials:
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Randomized, Controlled, Observer-blind Psoriasis Plaque Test to Investigate the Anti-psoriatic Efficacy, Tolerability and Safety (Skin Atrophy) of LAS41004 Formulations in Patients With Mild to Moderate Plaque Psoriasis |
Completed |
NCT02111499 |
Phase 1, Phase 2 |
LAS41004-IMP1;LAS41004 IMP2;LAS41004 IMP3;LAS41004 IMP4;LAS41004 IMP6;LAS41004 IMP5 |
2 |
An Open, Uncontrolled Pharmacokinetic Study With a New Topical Combination Gel Containing Triiodothyroacetic Acid (TRIAC) and Dehydroepiandrosterone (DHEA) in Subjects With Skin Atrophy Due to Topical Treatment With Glucocorticoids |
Unknown status |
NCT03783988 |
Phase 1 |
|
3 |
A Prospective, Randomised, Investigator-Blinded, Vehicle-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin |
Completed |
NCT02392130 |
Phase 1 |
Clobetasol propionate 0.05% ointment;LEO 130852A gel 1%;LEO 130852A placebo gel |
4 |
A Single-Centre, Explorative, Randomised, Investigator-Blinded, Negative-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess Steroid Induced Skin Atrophy on Healthy Skin |
Completed |
NCT02355639 |
Phase 1 |
Clobetasol propionate 0.05 % ointment;Betamethasone dipropionate 0.064 % ointment;Petrolatum ointment |
|